"Medications for opioid use disorder during the war in Ukraine: a more comprehensive view on the government response-Authors' reply"

Lancet Reg Health Eur. 2023 Jan 23:26:100583. doi: 10.1016/j.lanepe.2023.100583. eCollection 2023 Mar.

Daniel J Bromberg^{1

2}, Lynn M Madden^{3

4}, Anna Meteliuk⁵, Roman Ivasiy⁴, Samy J Galvez de Leon^{2

4}, Konstantin Klyucharyov⁶, Frederick L Altice^{2

3

4

7}

¹ Department of Social and Behavioral Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
² Yale Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, USA.
³ APT Foundation, New Haven, CT, USA.
⁴ Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA.
⁵ International Charitable Foundation "Alliance for Public Health", Kyiv, Ukraine.
⁶ Charitable Organization "Parus", Kharkiv, Ukraine.
⁷ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.

No abstract available

Keywords: MOUD, Medications for opioid use disorder; MoH, Ministry of Health; NIATx, Network for the Improvement of Addiction Treatment.

Grants and funding